Matches in Nanopublications for { ?s ?p "[To determine whether uridine diphosphate-glucuronosyltransferase 1A1, UGT1A7, and UGT1A9 polymorphisms affect the pharmacokinetics (PK) of irinotecan and treatment outcome of Korean patients with advanced non-small-cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP646448.RAlUNCV5ZlMtzv32A4mF1bgk-knH4YROE2xhydHOn9mlw130_assertion description "[To determine whether uridine diphosphate-glucuronosyltransferase 1A1, UGT1A7, and UGT1A9 polymorphisms affect the pharmacokinetics (PK) of irinotecan and treatment outcome of Korean patients with advanced non-small-cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646448.RAlUNCV5ZlMtzv32A4mF1bgk-knH4YROE2xhydHOn9mlw130_provenance.
- NP624368.RAk4x808dO4Wnv9S0Mpz_DVUCJ616tigFlKWxr3_WDIaY130_assertion description "[To determine whether uridine diphosphate-glucuronosyltransferase 1A1, UGT1A7, and UGT1A9 polymorphisms affect the pharmacokinetics (PK) of irinotecan and treatment outcome of Korean patients with advanced non-small-cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624368.RAk4x808dO4Wnv9S0Mpz_DVUCJ616tigFlKWxr3_WDIaY130_provenance.
- NP287107.RA-KbQWCbBzMScGrUsNTp_HGoiveVSHbgXOnXE4pY8i60130_assertion description "[To determine whether uridine diphosphate-glucuronosyltransferase 1A1, UGT1A7, and UGT1A9 polymorphisms affect the pharmacokinetics (PK) of irinotecan and treatment outcome of Korean patients with advanced non-small-cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287107.RA-KbQWCbBzMScGrUsNTp_HGoiveVSHbgXOnXE4pY8i60130_provenance.
- NP546595.RAD2Y0vlOXECGxPIf8CUM6ZNcFraaUlU4Hbyp4ne6dYuc130_assertion description "[To determine whether uridine diphosphate-glucuronosyltransferase 1A1, UGT1A7, and UGT1A9 polymorphisms affect the pharmacokinetics (PK) of irinotecan and treatment outcome of Korean patients with advanced non-small-cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP546595.RAD2Y0vlOXECGxPIf8CUM6ZNcFraaUlU4Hbyp4ne6dYuc130_provenance.
- NP912594.RAXS6dJORsDSF6-zW1MqEY_nYqqag3KaYS63sUTFF4vZA130_assertion description "[To determine whether uridine diphosphate-glucuronosyltransferase 1A1, UGT1A7, and UGT1A9 polymorphisms affect the pharmacokinetics (PK) of irinotecan and treatment outcome of Korean patients with advanced non-small-cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP912594.RAXS6dJORsDSF6-zW1MqEY_nYqqag3KaYS63sUTFF4vZA130_provenance.
- assertion description "[To determine whether uridine diphosphate-glucuronosyltransferase 1A1, UGT1A7, and UGT1A9 polymorphisms affect the pharmacokinetics (PK) of irinotecan and treatment outcome of Korean patients with advanced non-small-cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To determine whether uridine diphosphate-glucuronosyltransferase 1A1, UGT1A7, and UGT1A9 polymorphisms affect the pharmacokinetics (PK) of irinotecan and treatment outcome of Korean patients with advanced non-small-cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP912305.RAnJXCUZlKOFGpFES5-q3UUY_YoxbZ8BkqLR2TaikVKtY130_assertion description "[To determine whether uridine diphosphate-glucuronosyltransferase 1A1, UGT1A7, and UGT1A9 polymorphisms affect the pharmacokinetics (PK) of irinotecan and treatment outcome of Korean patients with advanced non-small-cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP912305.RAnJXCUZlKOFGpFES5-q3UUY_YoxbZ8BkqLR2TaikVKtY130_provenance.
- NP546592.RAhEfJgHK0uC8bpX3XCFfLKeV9b3K2sQGYBpuzPPtD4fA130_assertion description "[To determine whether uridine diphosphate-glucuronosyltransferase 1A1, UGT1A7, and UGT1A9 polymorphisms affect the pharmacokinetics (PK) of irinotecan and treatment outcome of Korean patients with advanced non-small-cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP546592.RAhEfJgHK0uC8bpX3XCFfLKeV9b3K2sQGYBpuzPPtD4fA130_provenance.